Alessandro Cagol1,2,3, Mario Ocampo-Pineda1,2,3, Lester Melie-Garcia1,2,3, Po-Jui Lu1,2,3, Muhamed Barakovic1,2,3, Matthias Weigel1,2,3,4, Xinjie Chen1,2,3, Antoine Lutti5, Thanh D. Nguyen6, Yi Wang6, Jens Kuhle2,3, Ludwig Kappos1,2,3, and Cristina Granziera1,2,3
1Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland, 2Department of Neurology, University Hospital Basel, Basel, Switzerland, 3Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, 4Division of Radiological Physics, Department of Radiology, University Hospital Basel, Basel, Switzerland, 5Laboratory for Research in Neuroimaging, Department of Clinical Neuroscience, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, 6Department of Radiology, Weill Cornell Medical College, New York, NY, United States
Synopsis
Keywords: Multiple Sclerosis, Quantitative Imaging
We explored the value of multiple
longitudinal quantitative MRI (qMRI) measures in detecting
microstructural changes occurring in normal-appearing tissue of
patients with multiple sclerosis (PwMS).
While no differences in qMRI
longitudinal changes were measured between PwMS and healthy
controls,
progressive PwMS showed accelerated T1-relaxometry increase in
normal-appearing tissue with respect to both healthy controls and
relapsing-remitting PwMS, reflecting increased micro/macrostructural
damage.
In PwMS the rates of qMRI changes
during follow-up were associated with the severity of clinical
disability, with higher neurological impairment being associated with
qMRI changes reflecting accelerated micro/macrostructural damage,
demyelination, and axon/dendrite loss.
Introduction
Multiple sclerosis (MS) is a
chronic disease of the central nervous system characterized by a
complex interplay between inflammatory, demyelinating, and
neurodegenerative processes.(1)
Despite MS lesions represent the
diagnostic hallmark of the disease, correlation between lesion burden
and clinical findings is generally weak.(2)
Indeed, substantial contribution to clinical disability is also
attributable to diffuse, heterogeneous pathological changes occurring
in the normal-appearing tissue.(3)
By providing biophysical markers of
microstructural
integrity, quantitative MRI (qMRI) enables the in
vivo
characterization of tissue damage.(4)
The aim of the study was to
investigate longitudinal changes of multiple qMRI measures in
normal-appearing tissue of patients with multiple sclerosis (PwMS),
and to explore their association with clinical measures. As qMRI of
interest we included: 1) T1-relaxometry (qT1); 2) magnetization
transfer saturation (MTsat); 3) myelin water fraction (MWF); 4)
quantitative susceptibility mapping (QSM); and 5) neurite density
index (NDI), representing surrogate measures of micro/macrostructural
tissue integrity, macromolecular integrity, myelin content, iron
content, and axon/dendrite density, respectively.(4)
Figure1
Methods
From
an ongoing prospective study we included 50 healthy controls (HCs)
and 81 PwMS having 2-year clinical and MRI follow-up.Table1
All
subjects underwent the same MRI protocol, at baseline and after 2
years, on a 3T scanner (Magnetom Prisma, Siemens Helthcare),
including: (1) 3D-FLAIR [TR/TE/TI =
5000ms/386ms/1800ms/1x1x1mm3];
(2) 3D-MP2RAGE [TR/TI1/TI2/resolution =
5000ms/700ms/2500ms/1x1x1mm3];
(3) FAST-T2 [spiral TR/TE = 7.5/0.5 ms, six T2prep
times=0/7.5/17.5/67.5/147.5/307.5ms, resolution=1.25x1.25x5mm3];
(4) multi-shell diffusion (TR/TE/resolution =
4.5s/75ms/1.8x1.8x1.8mm3;
b-values = 0/700/1000/2000/3000s/mm2);
(5) 3D-EPI (TR/TE/resolution = 64ms/35ms/0.67×0.67×0.67mm3).
T1maps were computed from MP2RAGE;(6)
quantitative
MTsat images were obtained using three 3D RF spoiled gradient echo
acquisitions with predominantly Magnetization Transfer-weighted
(MTw:TR/α=25ms/5o), proton density-weighted (PDw:TR/α=5ms/5o) and
T1-weighted (T1w:TR/α=11ms/15o) contrast;(7)
MWF maps were obtained from FAST-T2;(8)
QSM was reconstructed from 3D EPI;(9)
NDI was derived with the NODDI model.(10)
T2-lesion
volume (T2LV) was quantified semi-automatically on FLAIR images;
cortical lesions were manually segmented on MP2RAGE. Brain volumes
were automatically segmented on MP2RAGE using SAMSEG.(11,12) T2LV
and cortical lesions volume were subtracted from the resulting masks
to obtain segmentations of normal-appearing white matter (NAWM),
normal-appearing deep gray matter (NADGM), and normal-appearing
cerebral cortex (NAC). We then extracted mean qMRI values in NAWM
(for all contrasts), NADGM (for qT1, MTsat, QSM, and NDI), and NAC
(for qT1 and MTsat).
Baseline differences in qMRI
measures between PwMS and HCs were explored with general linear
models, adjusting for age, and sex. Rates of longitudinal qMRI
changes were investigated with linear mixed effect models, using qMRI
measures at each time point as dependent variables, subjects as
random intercept, and time, age, and sex as covariates. Associations
between qMRI longitudinal changes and 1) MS subtype, 2) Expanded
Disability Status Scale (EDSS), and 3) T2LV change during follow-up
were explored by introducing in the above-mentioned models the
interaction term between such variables and time. False discovery
rate (FDR) approach was used to adjust for multiple comparisons.Results
At baseline, PwMS showed increased
values of qT1, and reduced values of MTsat and NDI in the NAWM (all
FDR-p<0.0001), when compared to HCs. Additionally, increased qT1
values were detected in NAC (FDR-p=0.011) and NADGM (FDR-p=0.006),
while reduced MTsat values were measured in NAC (FDR-p=0.003).Figure2
No differences in longitudinal
rates of qMRI changes were found between HCs and the entire cohort of
PwMS; conversely, accelerated rates of increase in qT1 values were
detected in progressive MS (PMS) patients with respect to HCs in the
NAWM (FDR-p=0.005), NADGM (FDR-p=0.005), and NAC (FDR-p=0.004). PMS
patients also showed significantly accelerated longitudinal qT1
increase with respect to relapsing-remitting (RRMS) patients, in both
NAWM (FDR-p=0.019) and NAC (FDR-p=0.015).Figure3
Baseline disability was
significantly associated with the rates of qMRI change. Specifically,
higher baseline EDSS was associated with accelerated qT1 increase in
NAWM (FDR-p=0.045) and NAC (FDR-p=0.045), as well with accelerated
reduction of 1) MTsat values in NAWM (FDR-p=0.019) and NAC
(FDR-p=0.019), 2) MWF in NAWM (FDR-p=0.001), and 3) NDI in NADGM
(FDR-p=0.037).Table2
The accumulation of T2LV during
follow-up showed a significant association with the rate of change of
MTsat values in NAWM (β=-0.144;
FDR-p=0.047).Discussion
In this study we showed that a
significant difference in the longitudinal rates of qMRI changes in
normal-appearing tissue can be measured in patients with PMS with
respect to both HCs and RRMS patients, over a 2-year follow-up.
Specifically, the rate of increase of qT1 in PMS was significantly
accelerated, involving concomitantly the white matter and gray matter
(both in the cerebral cortex, and deep gray matter), reflecting
greater accumulation of micro/macrostructural damage.
The rates of qMRI changes were
associated with the severity of clinical disability, with patients
with higher neurological impairment showing accelerated qMRI changes,
a fact that is most probably reflecting increased
micro/macrostructural damage, demyelination, and axon/dendrite loss
in this patients group.
Finally, we found that focal
inflammatory activity during follow-up correlated with longitudinal
MTsat changes, reflecting increased macromolecular damage in NAWM.Conclusion
Patients with PMS are characterized
by accelerated longitudinal rates of qT1 increase in normal-appearing
tissue, suggesting greater accumulation of micro/macrostructural
damage. PwMS with higher disability showed the most severe
longitudinal qMRI changes, reflecting accelerated
micro/macrostructural damage, demyelination, and axon/dendrite loss.Acknowledgements
No acknowledgement found.References
1. Stadelmann C, Wegner C, Brück
W. Inflammation, demyelination, and degeneration - Recent insights
from MS pathology [Internet]. Vol. 1812, Biochimica et Biophysica
Acta - Molecular Basis of Disease. Biochim Biophys Acta; 2011 [cited
2021 Sep 13]. p. 275–82. Available from:
https://pubmed.ncbi.nlm.nih.gov/20637864/
2. Barkhof F. The
clinico-radiological paradox in multiple sclerosis revisited. Curr
Opin Neurol [Internet]. 2002 [cited 2022 Nov 6];15(3):239–45.
Available from: https://pubmed.ncbi.nlm.nih.gov/12045719/
3. Lassmann H. Multiple
Sclerosis Pathology. Cold Spring Harb Perspect Med [Internet]. 2018
Mar 1 [cited 2022 Nov 6];8(3). Available from:
/pmc/articles/PMC5830904/
4. Granziera C, Wuerfel J,
Barkhof F, Calabrese M, De Stefano N, Enzinger C, et al. Quantitative
magnetic resonance imaging towards clinical application in multiple
sclerosis [Internet]. Vol. 144, Brain. Brain; 2021 [cited 2022 Nov
6]. p. 1296–311. Available from:
https://pubmed.ncbi.nlm.nih.gov/33970206/
5. York EN, Meijboom R,
Thrippleton MJ, Mark E, Kampaite A, White N, et al. Magnetisation
transfer, diffusion and g-ratio measures of demyelination and
neurodegeneration in early relapsing-remitting multiple sclerosis: a
longitudinal microstructural MRI study. NeuroImage Clin [Internet].
2022 Jan 1 [cited 2022 Nov 6];36:1–49. Available from:
https://linkinghub.elsevier.com/retrieve/pii/S2213158222002935
6. Marques JP, Kober T,
Krueger G, van der Zwaag W, Van de Moortele PF, Gruetter R. MP2RAGE,
a self bias-field corrected sequence for improved segmentation and
T1-mapping at high field. Neuroimage [Internet]. 2010 Jan 15 [cited
2022 Nov 6];49(2):1271–81. Available from:
https://pubmed.ncbi.nlm.nih.gov/19819338/
7. Helms G, Dathe H, Dechent
P. Quantitative FLASH MRI at 3T using a rational approximation of the
Ernst equation. Magn Reson Med [Internet]. 2008 [cited 2022 Nov
6];59(3):667–72. Available from:
https://pubmed.ncbi.nlm.nih.gov/18306368/
8. Nguyen TD, Deh K, Monohan
E, Pandya S, Spincemaille P, Raj A, et al. Feasibility and
reproducibility of whole brain myelin water mapping in 4 minutes
using fast acquisition with spiral trajectory and adiabatic T2prep
(FAST-T2) at 3T. Magn Reson Med [Internet]. 2016 Aug 1 [cited 2021
Nov 24];76(2):456–65. Available from:
https://pubmed.ncbi.nlm.nih.gov/26331978/
9. Liu T, Xu W, Spincemaille
P, Avestimehr AS, Wang Y. Accuracy of the morphology enabled dipole
inversion (MEDI) algorithm for quantitative susceptibility mapping in
MRI. IEEE Trans Med Imaging [Internet]. 2012 Mar [cited 2022 Aug
25];31(3):816–24. Available from:
https://pubmed.ncbi.nlm.nih.gov/22231170/
10. Zhang H, Schneider T,
Wheeler-Kingshott CA, Alexander DC. NODDI: Practical in vivo neurite
orientation dispersion and density imaging of the human brain.
Neuroimage [Internet]. 2012 Jul 16 [cited 2022 Nov 6];61(4):1000–16.
Available from: https://pubmed.ncbi.nlm.nih.gov/22484410/
11. Puonti O, Iglesias JE,
Van Leemput K. Fast and sequence-adaptive whole-brain segmentation
using parametric Bayesian modeling. Neuroimage. 2016 Dec
1;143:235–49.
12.
Cerri S, Puonti O, Meier DS, Wuerfel J, Mühlau M, Siebner HR, et
al. A contrast-adaptive method for simultaneous whole-brain and
lesion segmentation in multiple sclerosis. Neuroimage. 2021 Jan
15;225:117471.